Inactive Instrument

All News Novus Therapeutics, Inc. Nasdaq

Equities

All News

Unlock all the news: Be the first to know and act before the market!

Eledon to Participate in the Leerink Partners Therapeutics Forum: I&I and Metabolism	01:35am	GL
Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	04/06	GL
Eledon Pharmaceuticals, Inc. Presents Updated Data from Ongoing Phase 1B Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	04/06	CI
Eledon Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results	09/05	GL
Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress	09/05	GL
Eledon Pharmaceuticals, Inc. announced that it has received $49.99901 million in funding	09/05	CI
Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	07/05	GL
Eledon Pharmaceuticals, Inc. Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	07/05	CI
Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement	07/05	GL
Eledon Pharmaceuticals, Inc. announced that it expects to receive $49.99901 million in funding	06/05	CI
Eledon Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03	CI
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	29/03	GL
Eledon Pharmaceuticals Says 12th Participant Enrolled in Tegoprubart Trial; Shares Rise After Hours	26/03	MT
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	26/03	GL
Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	26/03	CI
Sector Update: Health Care Stocks Higher in Late Afternoon Trading	22/03	MT
Sector Update: Health Care	22/03	MT
Eledon Pharmaceuticals Says Tegoprubart Used in Kidney Transplant From Pig to Human	22/03	MT
Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	21/03	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Novus Therapeutics, Inc. Nasdaq

Equities

All News

Filters